Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
about
Obligatory role of NR2A for metaplasticity in visual cortexInduction of serine racemase expression and D-serine release from microglia by amyloid beta-peptideNMDA Receptor Function During Senescence: Implication on Cognitive PerformanceN-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's diseaseMolecular bases of NMDA receptor subtype-dependent propertiesGlutamate receptor ion channels: structure, regulation, and functionNMDA and dopamine converge on the NMDA-receptor to induce ERK activation and synaptic depression in mature hippocampusThe immediate early gene early growth response gene 3 mediates adaptation to stress and novelty.Benchmark IV Progressing Nicely: Rational Pharmacotherapy May Address Cognitive Decline in Epilepsy.Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.Neuronal transporters regulate glutamate clearance, NMDA receptor activation, and synaptic plasticity in the hippocampusCo-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapsesPresynaptic NMDA receptors mediate IPSC potentiation at GABAergic synapses in developing rat neocortex.The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus.Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptorsStructural mechanism of N-methyl-D-aspartate receptor type 1 partial agonismGene Expression Switching of Receptor Subunits in Human Brain Development.Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related BehaviorSynapse-specific expression of functional presynaptic NMDA receptors in rat somatosensory cortexIdentity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus.A role for glutamate in subjective response to smoking and its action on inhibitory control.New advances in NMDA receptor pharmacology.Circuit-specific changes in D-serine-dependent activation of the N-methyl-D-aspartate receptor in the aging hippocampus.The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspectiveEffects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cellsMolecular pharmacology of human NMDA receptorsAmygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.Bidirectional neuro-glial signaling modalities in the hypothalamus: role in neurohumoral regulation.Induction- and conditioning-protocol dependent involvement of NR2B-containing NMDA receptors in synaptic potentiation and contextual fear memory in the hippocampal CA1 region of rats.Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap.Coagonist release modulates NMDA receptor subtype contributions at synaptic inputs to retinal ganglion cells.Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's diseaseExtracellular glutamate concentration in hippocampal sliceD-cycloserine enhances short-delay, but not long-delay, conditioned taste aversion learning in ratsAllosteric modulators for the treatment of schizophrenia: targeting glutamatergic networksPresynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticityKinetic basis of partial agonism at NMDA receptors.Retinal NMDA receptor function and expression are altered in a mouse lacking D-amino acid oxidasePharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
P2860
Q24670490-E0369CCD-A44D-4800-8F98-60279FF821FEQ24794350-B9EC8DC8-491F-4D10-AA72-5207614F1C40Q26770902-2DC4E650-9790-46E0-8404-5719E593DE9EQ26825619-F9F69DC1-C640-42FA-87F0-4E368008A1ECQ27012689-D13BB69E-16BF-4DB8-9C72-A9DD37041315Q28290774-E087CA71-BDDF-41C0-9458-C322BCDA0EB8Q28469102-D9AD76E6-C4FB-4C9D-A1D3-B7EBD350914AQ30492246-640AB3C0-D356-4A0F-9710-DAB584786E8AQ33569766-CAC9F383-AB0B-41AC-A830-C7D57E5A022BQ33702430-C498D842-A9B8-4E1E-BC50-73AE1E5D87DEQ33783651-1C9A655A-1B8C-4A92-B9A5-9A7CF9FA9337Q33784099-04C3FA91-7039-41C3-A894-E249A7D21FB4Q33834134-5D0F3868-4145-4B68-B41B-7A126BDBB4CAQ33920257-0447DCA9-D389-425D-BED0-585F26A7AA4BQ33923662-F4036F2A-7086-4430-8D57-6B652D8C1AABQ34208684-781C0B17-DC37-48EC-AA78-4195E357AF1DQ34451002-9EB6DBDB-9822-4ECE-9465-4D64CE70A8FEQ34504116-56465C5A-8AA1-4F85-9F35-F9938198C1C2Q34653628-1B1B8442-8276-4073-B7E4-6AF1C30BC24CQ34767389-C54A216C-8CEF-4E97-A3E1-E87419E720B0Q34985616-3835159A-BFD6-4027-B146-075944C9D847Q35035848-B905B23F-F481-4292-A342-27AD5EC6C140Q35570829-F9E3364E-FC18-4E20-9805-285188265004Q35678615-D146007C-8D4F-41D0-B0AA-7187CA6BB39DQ35861036-6CCFB719-162F-4C29-B35A-1EB268E4F642Q35884655-5523E5CD-3903-4219-806A-8FF454B7D0F4Q35911379-A93EA75F-A315-48AC-9FD3-3860CA474798Q36411139-A0A90F73-4FBB-4C8D-8150-FB82EA853F40Q36882293-73D21B4D-D94A-4121-81F7-864293FE9E79Q36944372-218FF5C7-572A-4211-91CF-3E20751FB0EBQ36962792-28B864D2-87F3-4312-AF56-3A4D2C32826EQ37116308-60AAF8D4-EF5A-47C5-95F6-46B5DD3C06F9Q37155987-12E2ED78-277E-4207-B8BD-AFC7EBA12964Q37163189-32F1E319-B151-4DAE-9286-DF9A91B6A863Q37198881-3BFF687D-804F-40D8-B239-46E8296C8FC6Q37220392-B8338254-C1FB-454B-91C7-BC111D8F01CAQ37333350-24C7C412-6951-4CA6-8FE2-1283A59F0879Q37337383-CD38C6C8-4CBB-4FE8-A1E6-B31667A719BCQ37441423-F0FE3B27-ECE9-4318-8D99-3D74EB6728B0Q37978091-50929C28-4CE5-4395-9A80-2BC5C4802E55
P2860
Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Pharmacological properties of ...... fected mouse fibroblast cells.
@en
type
label
Pharmacological properties of ...... fected mouse fibroblast cells.
@en
prefLabel
Pharmacological properties of ...... fected mouse fibroblast cells.
@en
P2093
P1476
Pharmacological properties of ...... fected mouse fibroblast cells.
@en
P2093
Laughton P
Le Bourdellés B
Priestley T
Whiting PJ
P304
P577
1995-11-01T00:00:00Z